ELEVANCE HEALTH, INC. Operating Lease, Payments
ELEVANCE HEALTH, INC. (ELV) reported Operating Lease, Payments of $176.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-02-06
- ELEVANCE HEALTH, INC. operating lease, payments for the quarter ending 2023-12-31 was $50.00M, a 8.70% increase year-over-year.
- ELEVANCE HEALTH, INC. operating lease, payments for the quarter ending 2023-09-30 was $53.00M, a 0.00% change year-over-year.
- ELEVANCE HEALTH, INC. operating lease, payments for the quarter ending 2023-06-30 was $54.00M, a 1.89% increase year-over-year.
- ELEVANCE HEALTH, INC. operating lease, payments for the quarter ending 2023-03-31 was $52.00M, a 1.89% decline year-over-year.
- ELEVANCE HEALTH, INC. operating lease, payments for fiscal 2025 was $176.00M, a 12.87% decline from fiscal 2024.
- ELEVANCE HEALTH, INC. operating lease, payments for fiscal 2024 was $202.00M, a 1.94% decline from fiscal 2023.
- ELEVANCE HEALTH, INC. operating lease, payments for fiscal 2023 was $206.00M, a 0.98% increase from fiscal 2022.
- ELEVANCE HEALTH, INC. operating lease, payments for fiscal 2022 was $204.00M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $176.00M 10-K · filed 2026-02-06 | |||
| 2024-12-31 | $202.00M 10-K · filed 2026-02-06 | |||
| 2023-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $103.00M derived: sum of 2 quarters · filed 2025-02-20 | $157.00M derived: sum of 3 quarters · filed 2025-02-20 | $206.00M 10-K · filed 2025-02-20 |
| 2023-09-30 | $53.00M 10-Q · filed 2023-10-18 | $107.00M derived: sum of 2 quarters · filed 2023-10-18 | $156.00M 10-Q · filed 2023-10-18 | $205.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2023-06-30 | $54.00M 10-Q/A · filed 2023-09-29 | $105.00M 10-Q/A · filed 2023-09-29 | $152.00M derived: sum of 3 quarters · filed 2024-02-21 | $205.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2023-03-31 | $52.00M 10-Q · filed 2023-04-19 | $98.00M derived: sum of 2 quarters · filed 2024-02-21 | $151.00M derived: sum of 3 quarters · filed 2024-02-21 | $204.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-12-31 | $46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $99.00M derived: sum of 2 quarters · filed 2024-02-21 | $152.00M derived: sum of 3 quarters · filed 2024-02-21 | $204.00M 10-K · filed 2024-02-21 |
| 2022-09-30 | $53.00M 10-Q · filed 2023-10-18 | $106.00M derived: sum of 2 quarters · filed 2023-10-18 | $158.00M 10-Q · filed 2023-10-18 | $216.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2022-06-30 | $53.00M 10-Q/A · filed 2023-09-29 | $105.00M 10-Q/A · filed 2023-09-29 | $163.00M derived: sum of 3 quarters · filed 2023-10-18 | $216.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2022-03-31 | $53.00M 10-Q · filed 2023-04-19 | $110.00M derived: sum of 2 quarters · filed 2023-10-18 | $163.00M derived: sum of 3 quarters · filed 2023-10-18 | $199.00M derived: sum of 4 quarters · filed 2023-10-18 |
| 2021-12-31 | $57.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-10-18 | $110.00M derived: sum of 2 quarters · filed 2023-10-18 | $146.00M derived: sum of 3 quarters · filed 2023-10-18 | $198.00M 10-Q · filed 2023-10-18 |
| 2021-09-30 | $53.00M 10-Q · filed 2022-10-19 | $89.00M derived: sum of 2 quarters · filed 2022-10-19 | $141.00M 10-Q · filed 2022-10-19 | $211.00M derived: sum of 4 quarters · filed 2022-10-19 |
| 2021-06-30 | $36.00M 10-Q · filed 2022-07-20 | $88.00M 10-Q · filed 2022-07-20 | $158.00M derived: sum of 3 quarters · filed 2022-07-20 | $205.00M derived: sum of 4 quarters · filed 2022-07-20 |
| 2021-03-31 | $52.00M 10-Q · filed 2022-04-20 | $122.00M derived: sum of 2 quarters · filed 2022-04-20 | $169.00M derived: sum of 3 quarters · filed 2022-04-20 | $215.00M derived: sum of 4 quarters · filed 2022-04-20 |
| 2020-12-31 | $70.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $117.00M derived: sum of 2 quarters · filed 2022-02-16 | $163.00M derived: sum of 3 quarters · filed 2022-02-16 | $207.00M 10-K · filed 2022-02-16 |
| 2020-09-30 | $47.00M 10-Q · filed 2021-10-20 | $93.00M derived: sum of 2 quarters · filed 2021-10-20 | $137.00M 10-Q · filed 2021-10-20 | $181.00M derived: sum of 4 quarters · filed 2021-10-20 |
| 2020-06-30 | $46.00M 10-Q · filed 2021-07-21 | $90.00M 10-Q · filed 2021-07-21 | $134.00M derived: sum of 3 quarters · filed 2021-07-21 | $177.00M derived: sum of 4 quarters · filed 2021-07-21 |
| 2020-03-31 | $44.00M 10-Q · filed 2021-04-21 | $88.00M derived: sum of 2 quarters · filed 2021-04-21 | $131.00M derived: sum of 3 quarters · filed 2021-04-21 | $175.00M derived: sum of 4 quarters · filed 2021-04-21 |
| 2019-12-31 | $44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $87.00M derived: sum of 2 quarters · filed 2021-02-18 | $131.00M derived: sum of 3 quarters · filed 2021-02-18 | $176.00M 10-K · filed 2021-02-18 |
| 2019-09-30 | $43.00M 10-Q · filed 2020-10-28 | $87.00M derived: sum of 2 quarters · filed 2020-10-28 | $132.00M 10-Q · filed 2020-10-28 | |
| 2019-06-30 | $44.00M 10-Q · filed 2020-07-29 | $89.00M 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $44.00M 10-Q · filed 2020-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |